Retinol Binding Protein RBP Rid Kit
FDA 510(k) K973189 · The Binding Site, Ltd.
510(k) numberK973189
Submission
- Device name
- Retinol Binding Protein RBP Rid Kit
- Applicant
- The Binding Site, Ltd.
Santa Monica, CA, US - Received
- August 25, 1997
- Decision date
- September 29, 1997
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- CZS – Retinol-Binding Protein, Antigen, Antiserum, Control
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 866.5765
- Specialty
- Immunology
Other 510(k)s with product code CZS
More from Behring Diagnostics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K231290 | Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitDFH · Traditional | 01/24/2024SE |
| K140105 | Hevylite Human Iga Kappa Kit for Use on Siemens Bnii, Hevylite Human Iga Lambda Kit for…OPX · Traditional | 03/18/2014SE |
| K132555 | Hevylite Human Igg Kappa Kit and Hevylite Human Igg Lambda KitPCN · Traditional | 12/20/2013SE |
| K103824 | Human Iga Liquid Reagent Kit for Use on SPA PlusCFN · Traditional | 02/27/2012SE |
| K100455 | Spaplus AnalyzerDBI · Traditional | 09/03/2010SE |
| K090920 | Human Igg Subclass Liquid Reagent Kits (for Use on Hitachi 911/ 912/ 917 and Modular P)CFN · Traditional | 12/30/2009SE |
| K092450 | Human Igd Kit for Use on SpaplusCZJ · Traditional | 12/28/2009SE |
| K083289 | Human BETA-2 Microglobulin KitJZG · Traditional | 05/06/2009SE |
| K082129 | Human Igm Liquid Reagent Kit for Use on the Spaplus AnalyzerCFN · Traditional | 02/10/2009SE |
| K081827 | Human Iga Liquid Reagent Kit for Use on SpaplusCFN · Traditional | 12/19/2008SE |
Questions and answers
When was Retinol Binding Protein RBP Rid Kit cleared by the FDA?
Retinol Binding Protein RBP Rid Kit (K973189) received a 510(k) decision of Substantially Equivalent on September 29, 1997, 35 days after the submission was received.
What is the product code of K973189?
The FDA product code is CZS – Retinol-Binding Protein, Antigen, Antiserum, Control, a Class I (low risk) device regulated under 21 CFR 866.5765.